Get started
Author

Veronica Bazzurri

Observed names: V Bazzurri, V. Bazzurri
ORCID: 0000-0002-6071-393X
Observed ORCID: 0000-0002-6071-393X
OpenAlex ID: A5064407085
Spinal cord lesions are frequently asymptomatic in relapsing–remitting multiple sclerosis: a retrospective MRI survey
2019 · Franco Granella, Elena Tsantes, et al. · Journal of Neurology · 31
Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study
2024 · K. Smolik, F. Camilli, et al. · Multiple Sclerosis and Related Disorders · 19
PDF
Five- and seven-year prognostic value of new effectiveness measures (NEDA, MEDA and six-month delayed NEDA) in relapsing-remitting multiple sclerosis
2020 · Elena Tsantes, Erica Curti, et al. · Journal of the Neurological Sciences · 17
Prevalence of 2-year “No evidence of disease activity” (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study
2023 · V. Bazzurri, A. Fiore, et al. · Multiple Sclerosis and Related Disorders · 10
Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach
2022 · Paolo Immovilli, Nicola Morelli, et al. · Neurology International · 6
PDF
The contribution of enhancing lesions in monitoring multiple sclerosis treatment: is gadolinium always necessary?
2020 · Elena Tsantes, E. Curti, et al. · Journal of Neurology · 6
Ocrelizumab in tumefactive multiple sclerosis onset. A case report
2022 · V Bazzurri, E Curti, et al. · Neuroimmunology Reports · 4
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion
2021 · Alessia Fiore, Elena Tsantes, et al. · Headache The Journal of Head and Face Pain · 4
The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series
2022 · Paolo Immovilli, Paola De Mitri, et al. · Children · 3
PDF
A “Post-mortem” of COVID-19-associated stroke: a case-control study
2022 · Paolo Immovilli, Elena Marchesi, et al. · Journal of Stroke and Cerebrovascular Diseases · 3
PDF
Prevalence of 2-year “no evidence of disease activity” (NEDA-3 and NEDA-4) in relapsing-remitting multiple sclerosis. A real-world study
2021 · Veronica Bazzurri, Alessia Fiore, et al. · Journal of the Neurological Sciences
Works count: 11
Citation count: 103
H-index: 6
I10-index: 4
Year
Topic
Type